Prostate Cancer Information Center
Prostate cancer is the most commonly diagnosed cancer (other than skin cancer) among men in the United States. Each year, approximately 186,000 men will be diagnosed with prostate cancer. In order to reduce these numbers, researchers continue to explore new approaches to prostate cancer prevention. Work is also underway to refine tests used for the early detection of prostate cancer.
Advances in surgery, radiation therapy, and hormonal therapy have all contributed to improved prostate cancer survival. Currently, there are more than 2 million prostate cancer survivors living in the United States.
Understanding prostate cancer treatment options, the role of different doctors specializing in the treatment of prostate cancer, and how and when to access new and innovative prostate cancer treatment options available through clinical trials is essential in order to achieve the best outcome from prostate cancer treatment.
The Cancer Consultants Prostate Cancer Information Center has been designed to help patients understand options for prostate cancer prevention, early detection, and treatment, while providing ongoing information, inspiration, support, and community to individuals affected by a diagnosis of prostate cancer.
Headline Prostate Cancer News 
Approximately 16% of Worldwide Cancers Caused By Preventable Infections
About 16% of cancers worldwide are the result of preventable and treatable infections.
Vitamin E Supplementation Appears to Increase Risk of Prostate Cancer
Vitamin E increases the risk of prostate cancer by 17% compared to placebo.
Intensity-Modulated Radiation Therapy May Prove Better than Other Radiation Techniques for Prostate Cancer
Intensity-modulated radiation therapy may result in fewer adverse events and better outcomes than other radiation for prostate cancer.
Prostate Cancer Tips
Men who confront a cancer diagnosis before beginning or completing their families...
Women who confront a cancer diagnosis before beginning or completing their families...
You’ve probably heard of genetic testing for cancer susceptibility, but the more...
Prostate Cancer Management
Inspiration, Hope & Resources
Judith Giuliani: A Caregiver’s Perspective Rudy Giuliani’s wife discusses her partnership with her husband during his prostate...
Jack & Jill Late Stage Cancer Foundation Jon Albert, founder of the Jack & Jill Late Stage Cancer Foundation shows the...
Moving Bodies, Changing Lives Moving On Aerobics helps women regain joy of movement and physical fitness after...
Prostate Cancer Clinical Trials
HRRC03-376 – Investigation of Protein Biomarkers of Prostate Cancer
90203 – A Randomized Phase III Study of Neo-Adjuvant Docetaxel and Androgen Deprivation Prior to Radical Prostatectomy versus Immediate Radical Prostatectomy in Patients with High-Risk, Clinically Localized Prostate Cancer
AT-101-CS-205 – A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase 2 Study Comparing AT-101 in Combination with Docetaxel and Prednisone versus Docetaxel and Prednisone in Men with chemotherapy-Naïve Metastatic HRPC.




